Patents by Inventor Christopher Marrs

Christopher Marrs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210398253
    Abstract: During the rendering of an image, specific pixels in the image are identified where antialiasing would be helpful. Antialiasing is then performed on these identified pixels, where anti-aliasing is a technique used to add greater realism to a digital image by smoothing jagged edges. This reduces a cost of performing antialiasing by reducing a number of pixels within an image on which antialiasing is performed.
    Type: Application
    Filed: September 1, 2021
    Publication date: December 23, 2021
    Inventors: Adam Christopher Marrs, Josef B. Spjut, Holger Heinrich Gruen, Morgan McGuire, Rahul Sathe
  • Patent number: 11113790
    Abstract: During the rendering of an image, specific pixels in the image are identified where antialiasing would be helpful. Antialiasing is then performed on these identified pixels, where anti-aliasing is a technique used to add greater realism to a digital image by smoothing jagged edges. This reduces a cost of performing antialiasing by reducing a number of pixels within an image on which antialiasing is performed.
    Type: Grant
    Filed: March 25, 2019
    Date of Patent: September 7, 2021
    Assignee: NVIDIA CORPORATION
    Inventors: Adam Christopher Marrs, Josef B. Spjut, Holger Heinrich Gruen, Morgan McGuire, Rahul Sathe
  • Publication number: 20190318454
    Abstract: During the rendering of an image, specific pixels in the image are identified where antialiasing would be helpful. Antialiasing is then performed on these identified pixels, where anti-aliasing is a technique used to add greater realism to a digital image by smoothing jagged edges. This reduces a cost of performing antialiasing by reducing a number of pixels within an image on which antialiasing is performed.
    Type: Application
    Filed: March 25, 2019
    Publication date: October 17, 2019
    Inventors: Adam Christopher Marrs, Josef B. Spjut, Holger Heinrich Gruen, Morgan McGuire, Rahul Sathe
  • Publication number: 20190318455
    Abstract: During the rendering of an image, specific pixels in the image are identified where antialiasing would be helpful. Antialiasing is then performed on these identified pixels, where antialiasing is a technique used to add greater realism to a digital image by smoothing jagged edges. This reduces a cost of performing antialiasing by reducing a number of pixels within an image on which antialiasing is performed.
    Type: Application
    Filed: March 25, 2019
    Publication date: October 17, 2019
    Inventors: Holger Heinrich Gruen, Adam Christopher Marrs, Josef B. Spjut, Rahul Sathe, Morgan McGuire
  • Publication number: 20080187502
    Abstract: A method of assessing oxidative stress in a mammal is provided. The method comprises: a) exposing skin cells of said mammal to an oxidizable moiety; b) exposing said skin cells to an external aggression; and c) assessing a reaction product of said oxidizable moiety; wherein prior to said assessing step (c), said skin cells are non-invasively removed from said mammal such that said removed skin cells are viable. A personal care composition comprises a sunscreen, wherein said composition has an oxidation protection factor of at least about 40%.
    Type: Application
    Filed: February 2, 2007
    Publication date: August 7, 2008
    Inventors: Michelle Garay, Christopher Marrs, Michael Southall
  • Publication number: 20080025922
    Abstract: Bronzer compositions are provided. They comprise (a) water, (b) at least one water-soluble dye; and (c) at least one water-dispersible or water-soluble film-forming polymer. Optionally, a self-tanning agent such as 1,3-dihydroxyacetone may be present.
    Type: Application
    Filed: May 31, 2007
    Publication date: January 31, 2008
    Inventor: Christopher Marrs
  • Publication number: 20080014155
    Abstract: The present invention relates clear sunscreen compositions. The compositions include an organic sunscreen and an alcohol. In certain embodiments, the compositions include a rheology modifier such as a non-ionic polymer and an anti-pilling agent such as a cationic polymer.
    Type: Application
    Filed: May 31, 2007
    Publication date: January 17, 2008
    Inventor: CHRISTOPHER MARRS
  • Publication number: 20050042306
    Abstract: the present invention features a composition including (i) an oxygen labile active agent, and (ii) a plant extract selected from Chaparral extract, Rooibos extract, Arjuna extract, Cranberry extract, and Lapacho extract.
    Type: Application
    Filed: August 21, 2003
    Publication date: February 24, 2005
    Inventor: Christopher Marrs
  • Publication number: 20050042233
    Abstract: The present invention features a composition including (i) an oxygen labile active agent, and (ii) a fungal extract selected from ergothioneine and Phellinus Linteus extract.
    Type: Application
    Filed: August 21, 2003
    Publication date: February 24, 2005
    Inventor: Christopher Marrs
  • Publication number: 20050042309
    Abstract: The present invention features a composition including (i) an oxygen labile active agent, and (ii) a plant extract selected from Chrysanthellum extract, Neem extract, Lanatellys extract, Bacopa Monnieri extract, and Olive leaf extract.
    Type: Application
    Filed: August 21, 2003
    Publication date: February 24, 2005
    Inventor: Christopher Marrs
  • Publication number: 20050043217
    Abstract: The present invention features a composition including (i) an oxygen labile active agent and (ii) lactoglobulin.
    Type: Application
    Filed: August 21, 2003
    Publication date: February 24, 2005
    Inventor: Christopher Marrs
  • Patent number: 5985871
    Abstract: Compounds having a certain benzoxazine ring system and their precursors are disclosed which are useful for enhancing synaptic responses mediated by AMPA receptors. Also disclosed are methods for preparing such compounds, and methods for their use in treating subjects suffering from impaired nervous or intellectual functioning due to deficiencies in the number of excitatory synapses or in the number of AMPA receptors. The invention compounds can also be used for the treatment of non-impaired subjects for enhancing performance in sensory-motor and cognitive tasks which depend on brain networks utilizing AMPA receptors and for improving memory encoding.
    Type: Grant
    Filed: December 24, 1997
    Date of Patent: November 16, 1999
    Assignee: Cortex Pharmaceuticals, Inc.
    Inventors: Gary A. Rogers, Christopher Marrs